BioCentury
ARTICLE | Clinical News

Vi-rEPA vaccine: Pivotal

April 30, 2001 7:00 AM UTC

Results from a placebo-controlled trial of AVE’s Vi-EPA vaccine in 13,766 children in Vietnam showed that the vaccine was 91.5% effictive at preventing disease. Of 5,525 children who received 2 doses ...